Stockreport

Elevation Oncology Licenses ADC Technology from Synaffix to Drive Pipeline Expansion

LONZA GROUP AG UNSP/ADR  (LZAGY) 
NASDAQ:AMEX Investor Relations: lonza.com/about-lonza/investor-relations.aspx
PDF Licensing agreement gives Elevation Oncology access to Synaffix's ADC technology for one program in combination with SYNstatin E™Elevation Oncology nominates a novel HER [Read more]